跳至主要内容
临床试验/NCT03525990
NCT03525990已完成不适用

PRO-COM Project: Randomized-controlled Study Evaluating the Impact of Electronic Patient Reported Outcome (ePRO) Surveys on Patient-physician Communication and Quality of Life in Patients With Advanced Breast Cancer

Dr. Vera Trommet2 个研究点 分布在 1 个国家目标入组 62 人开始时间: 2018年1月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
62
试验地点
2
主要终点
Patient-physician communication

研究概览

简要总结

PRO-COM Project: Randomized-controlled study evaluating the impact of electronic patient reported outcome (ePRO) surveys on patient-physician communication and quality of life in patients with advanced breast cancer

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

性别
Female
接受健康志愿者
否

入选标准

  • •Stage IV breast cancer
  • •Start of a systemic anti cancer therapy: chemotherapy -/+ antibody therapy 1st until 3rd line (palliative), endocrine therapy or other therapy without limit
  • •Estimated life expectancy of minimum six months
  • •Signed informed consent
  • •No cognitive or speech impairments

排除标准

  • 未提供

研究组 & 干预措施

Intervention Arm

Active Comparator

Quality of life questionnaires (electronic patient reported outcomes) to be filled out by the patients at every visit. Quality of life data is fully available for physicians. Paper-based questionnaire (EORTC QLQ-COMU26) at baseline, after three months and after six months.

干预措施: Questionnaires (Other)

Control Arm

Placebo Comparator

Quality of life questionnaires (electronic patient reported outcomes) only to filled out by the patients at baseline, after three months and after six months. Quality of life data is hidden for physicians. Paper-based questionnaire (EORTC QLQ-COMU26) at baseline, after three months and after six months.

干预措施: Questionnaires (Other)

结局指标

主要结局

Patient-physician communication

时间窗: Up to six months

The communication between patient and physician will be assessed with EORTC QLQ-COMU26. Presumably some patients have privacy concerns with electronic questionnaires. The EORTC-COMU26 is the most important questionnaire in this study because it is needed for the primary endpoint. It contains sensitive questions about how the patient experiences the communication during the visit. In order to avoid patients not filling out the questionnaire due to privacy concerns or being afraid of giving an honest opinion and the physician could read it electronically, the EORTC QLQ-COMU26 is paper-based and the patients can hand them in in the study office.

次要结局

  • Quality of life assessment(Arm A: at every visit for six months; Arm B: at baseline, three months, six months)
  • Frequency of discontinuations of therapy(Up to six months)
  • Duration of communication between physician and patient(At baseline, three months, six months in both groups)

研究者

发起方
Dr. Vera Trommet
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Dr. Vera Trommet

Principal Investigator

Klinikum Wels-Grieskirchen

研究点 (2)

Loading locations...

相似试验

招募中
不适用
Implementing Individualized Patient Reported Outcome Measures in Routine Care of Patients With Coronary Artery DiseasePhysician-Patient RelationsPatient Acceptance of Health CareCoronary Artery Disease
NCT06164457University of Calgary200
已完成
不适用
Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing SurgeryStage IA Gastric CancerStage II Adult Liver CancerStage IIB Colorectal CancerStage IIIA Gastric CancerStage IVA Pancreatic CancerStage IIB Gastric CancerStage IIC Colorectal CancerStage IIIB Adult Liver CancerStage IVA Colorectal CancerStage I Adult Liver CancerStage IIB Pancreatic CancerStage IIIA Colorectal CancerStage I Colorectal CancerStage IIA Colorectal CancerStage IVA Liver CancerStage IVB Colorectal CancerStage IB Gastric CancerStage IB Pancreatic CancerStage IIA Pancreatic CancerStage IIIA Adult Liver CancerStage IV Gastric CancerStage IA Pancreatic CancerStage IIA Gastric CancerStage III Pancreatic CancerStage IIIB Colorectal CancerStage IIIB Gastric CancerStage IIIC Gastric CancerStage IIIC Adult Liver CancerStage IIIC Colorectal CancerStage IVB Liver CancerStage IVB Pancreatic Cancer
NCT02511821City of Hope Medical Center22
招募中
不适用
ePRO for the Timely Detection of Side Effects in Cancer Patients Undergoing CAR T ImmunotherapyCAR T-Cell TherapyPatient Reported Outcome Measures
NCT05354973Stiftung Swiss Tumor Institute11
终止
不适用
Electronic Patient Reported Outcomes in Measuring Health-Related Quality of Life in Patients With Stage I-IV Prostate Cancer Undergoing TreatmentProstate
NCT03197948Sidney Kimmel Cancer Center at Thomas Jefferson University20
已完成
不适用
Electronic Medical Record Reminders and Panel Management to Improve Primary Care of Elderly PatientsEMR Reminders to Improve Rates of Recommended Care
NCT01313169Beth Israel Deaconess Medical Center54
Study Evaluating the Impact of Electronic Surveys on... | 临床试验